Bipolar I Disorder Clinical Trials in Atlanta, Georgia
6 recruitingAtlanta, Georgia
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
DepressionBipolar I Disorder
AbbVie380 enrolled81 locationsNCT04777357
Recruiting
Phase 3
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
Bipolar DisorderBipolar I DisorderBipolar II Disorder+1 more
Xenon Pharmaceuticals Inc.400 enrolled28 locationsNCT07172516
Recruiting
Phase 2
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
Bipolar I DisorderBipolar II Disorder
AbbVie195 enrolled31 locationsNCT06696755
Recruiting
Phase 2
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
Bipolar I Disorder
LB Pharmaceuticals Inc.320 enrolled26 locationsNCT07494305
Recruiting
Phase 2
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
Bipolar I DisorderMania
Neurocrine Biosciences150 enrolled6 locationsNCT07288320
Recruiting
Phase 4
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
SchizophreniaBipolar I Disorder
Vanda Pharmaceuticals100 enrolled9 locationsNCT05648591